National Cancer Institute, Egypt
nci.cu.edu.egLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
131
Active
24
Phase 3
8
Total enrollment
10,461
Pipeline matrix
Showing 17 of 17 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Cyclophosphamide and Etoposide in combination | — | — | — | — | — | 1 | |
| Methotrexate | — | — | — | — | — | 1 | |
| Bupivacaine | — | — | — | — | — | 3 | |
| Erector spinae plane block | — | — | — | — | — | 2 | |
| Fentanyl + Dexmedetomidine | — | — | — | — | — | 1 | |
| Fentanyl | — | — | — | — | — | 1 | |
| conservative treatment | — | — | — | — | — | 1 | |
| Thoracic epidural block | — | — | — | — | — | 1 | |
| Nalbuphine | — | — | — | — | — | 1 | |
| Tramadol | — | — | — | — | — | 1 | |
| Bupivacaine + Magnesium | — | — | — | — | — | 1 | |
| Bupivacaine + Dexmedetomidine | — | — | — | — | — | 1 | |
| Intramuscular quadratus lumborum block | — | — | — | — | — | 1 | |
| Lateral quadratus lumborum block | — | — | — | — | — | 1 | |
| General anesthesia | — | — | — | — | — | 1 | |
| Mannitol | — | — | — | — | — | 1 | |
| Ringer's Lactate | — | — | — | — | — | 1 |
Next readouts
- 2024-06-01
- 2025-09-15
- 2025-12-06
- 2026-03-01
- 2026-04-01
- 2026-08
- 2026-08-01
- 2026-11-25
Top conditions
- Analgesia17
- Breast Cancer14
- Postoperative Pain7
- Pain, Postoperative5
- Erector Spinae Plane Block4
- Post-mastectomy Pain Syndrome4
- Postoperative Analgesia3
- Post-thoracotomy Pain Syndrome3
Frequently asked questions about National Cancer Institute, Egypt
- How many clinical trials does National Cancer Institute, Egypt have on ClinicalTrials.gov?
- National Cancer Institute, Egypt is listed as the lead sponsor on 131 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of National Cancer Institute, Egypt's trials are in Phase 3?
- 8 of National Cancer Institute, Egypt's trials are in Phase 3, spread across 17 active drug programs.
- What therapeutic areas does National Cancer Institute, Egypt focus on?
- National Cancer Institute, Egypt's most-studied conditions on ClinicalTrials.gov are Analgesia, Breast Cancer, Postoperative Pain, Pain, Postoperative, Erector Spinae Plane Block.
- When are National Cancer Institute, Egypt's next clinical trial readouts?
- National Cancer Institute, Egypt has 8 upcoming primary-completion readouts tracked here; the soonest is “Effect of Mannitol on Recovery Pattern After Orthognathic Surgery”, expected around 2024-06-01.